Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

ATRA US Equity

Atara Biotherapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1604464 · FY ends Dec 31
$9.60
+0.88 (+10.09%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 1 13D · 1 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Point72 Asset Management, L.P.sec.gov ↗
2026-08-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2513D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by Redmile Group, LLCsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-25

Every row is a filed document, checked against its EDGAR index.